Brief: Isofol Q3 Loss SEK 32.5 Mln
Nov 11 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* ISOFOL MEDICAL AB (PUBL) PUBLISHES INTERIM REPORT,
JANUARY-SEPTEMBER 2022
* Q3 NET REVENUE AMOUNTED TO TSEK 2,907 (5,154)
* Q3 RESULT FOR PERIOD TSEK -32,513 (-51,026)
Source text for Eikon: ID:nWkrb92g8J
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million
Brief: Isofol Medical Announces Bfarm Approval Of Optimized Phase Ib/Ii Study Design
Brief: Isofol Gets Gross Proceeds Of SEK 18.9 Mln In Connection With Exercise Of Warrants And Guarantee Commitments
Brief: Isofol Secures License Rights For Arfolitixorin In Autism